Report on Annual General Meeting proceedings ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) ("Aspen Holdings") Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively "Aspen" or "the Group") REPORT ON ANNUAL GENERAL MEETING PROCEEDINGS Shareholders are advised that, at the Annual General Meeting (AGM") of members held on Thursday, 9 December 2021, a total of 348 001 960 or 76,24% of issued shares (456 451 541) were voted. All ordinary, non-binding advisory votes, and special resolutions were passed by the requisite majority votes. The full voting statistics from this AGM are confirmed to be as follows: 1 Ordinary resolution number 1: Presentation and adoption of Annual Financial Statements For Against Abstain Shares voted 346 020 117 1 213 443 768 400 347 233 560 99,65% 0,35% 0,17% 76,07% 2 Ordinary resolution number 2: Presentation and noting of the Social & Ethics Committee Report For Against Abstain Shares voted 347 228 945 3 254 769 761 347 232 199 99,999% 0,001% 0,17% 76,07% 3 Ordinary resolution number 3.1: Re-election of Kuseni Dlamini retiring by rotation and available for re-election For Against Abstain Shares voted 321 890 226 25 885 174 226 560 347 775 400 92,56% 7,44% 0,05% 76,19% 4 Ordinary resolution number 3.2: Re-election of Ben Kruger retiring by rotation and available for re-election For Against Abstain Shares voted 343 533 163 4 243 060 225 737 347 776 223 98,78% 1,22% 0,05% 76,19% 5 Ordinary resolution number 3.3: Re-election of Themba Mkhwanazi retiring by rotation and available for re-election For Against Abstain Shares voted 346 055 695 1 720 407 225 858 347 776 102 99,51% 0,49% 0,05% 76,19% 6 Ordinary resolution number 3.4: Re-election of Babalwa Ngonyama retiring by rotation and available for re-election For Against Abstain Shares voted 344 200 016 3 576 086 225 858 347 776 102 98,97% 1,03% 0,05% 76,19% 7 Ordinary resolution number 4: Reappointment of Ernst & Young Inc. as independent external auditors For Against Abstain Shares voted 347 632 688 143 475 225 797 347 776 163 99,96% 0,04% 0,05% 76,19% 8 Ordinary resolution number 5.1: Election of Linda de Beer as a member of the Audit & Risk Committee For Against Abstain Shares voted 344 286 692 3 489 313 225 955 347 776 005 99,00% 1,00% 0,05% 76,19% 9 Ordinary resolution number 5.2: Election of Ben Kruger as a member of the Audit & Risk Committee For Against Abstain Shares voted 344 432 357 3 343 866 225 737 347 776 223 99,04% 0,96% 0,05% 76,19% 10 Ordinary resolution number 5.3: Election of Babalwa Ngonyama as a member of the Audit & Risk Committee For Against Abstain Shares voted 340 234 969 7 541 133 225 858 347 776 102 97,83% 2,17% 0,05% 76,19% 11 Ordinary resolution number 6: Unissued shares placed under the control of directors (5%) For Against Abstain Shares voted 285 558 552 62 217 045 226 363 347 775 597 82,11% 17,89% 0,05% 76,19% 12 Ordinary resolution number 7: General but restricted authority for the directors to issue shares for cash (5%) For Against Abstain Shares voted 287 130 562 60 645 655 225 743 347 776 217 82,56% 17,44% 0,05% 76,19% 13 Ordinary resolution number 8: Authorisation for an Executive Director to sign necessary documents For Against Abstain Shares voted 347 776 026 939 224 995 347 776 965 99,9997% 0,0003% 0,05% 76,19% 14 Non-binding advisory vote number 1: Endorsement of the remuneration policy by way of a non-binding advisory vote For Against Abstain Shares voted 333 327 182 14 263 088 411 690 347 590 270 95,90% 4,10% 0,09% 76,15% 15 Non-binding advisory vote number 2: Remuneration implementation report For Against Abstain Shares voted 329 507 509 18 082 056 412 395 347 589 565 94,80% 5,20% 0,09% 76,15% 16 Special resolution number 1.1a: Remuneration of non-executive directors - Chairman For Against Abstain Shares voted 347 312 814 463 091 226 055 347 775 905 99,87% 0,13% 0,05% 76,19% 17 Special resolution number 1.1b: Remuneration of non-executive directors - Board Member For Against Abstain Shares voted 347 313 686 462 219 226 055 347 775 905 99,87% 0,13% 0,05% 76,19% 18 Special resolution number 1.2a: Remuneration of non-executive directors - Audit & Risk Committee Chairman For Against Abstain Shares voted 347 312 984 462 921 226 055 347 775 905 99,87% 0,13% 0,05% 76,19% 19 Special resolution number 1.2b: Remuneration of non-executive directors - Audit & Risk Committee Member For Against Abstain Shares voted 347 313 084 462 219 226 657 347 775 303 99,87% 0,13% 0,05% 76,19% 20 Special resolution number 1.3a: Remuneration of non-executive directors - Remuneration & Nomination Committee Chairman For Against Abstain Shares voted 347 096 419 679 586 225 955 347 776 005 99,80% 0,20% 0,05% 76,19% 21 Special resolution number 1.3b: Remuneration of non-executive directors - Remuneration & Nomination Committee Member For Against Abstain Shares voted 347 097 281 678 724 225 955 347 776 005 99,80% 0,20% 0,05% 76,19% 22 Special resolution number 1.4a: Remuneration of non-executive directors - Social & Ethics Committee Chairman For Against Abstain Shares voted 347 313 144 462 861 225 955 347 776 005 99,87% 0,13% 0,05% 76,19% 23 Special resolution number 1.4b: Remuneration of non-executive directors - Social & Ethics Committee Member For Against Abstain Shares voted 347 313 144 462 159 226 657 347 775 303 99,87% 0,13% 0,05% 76,19% 24 Special resolution number 2: Financial assistance to related or inter-related company For Against Abstain Shares voted 334 632 698 13 142 796 226 466 347 775 494 96,22% 3,78% 0,05% 76,19% 25 Special resolution number 3: General authority to repurchase shares For Against Abstain Shares voted 340 746 256 7 012 699 243 005 347 758 955 97,98% 2,02% 0,05% 76,19% Durban 09 December 2021 Sponsor Investec Bank Limited Date: 09-12-2021 02:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Aspen Pharmacare Holdings Ltd. published this content on 09 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 December 2021 16:06:09 UTC.